News
With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...
These machines boost productivity by increasing folding speed, reducing manual effort, and minimising errors, Varad Deshpande ...
Eli Lilly is set to launch Mounjaro in KwikPen, a user-friendly, prefilled pen for weekly administration, in India, following ...
US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss ...
2h
Capital Market on MSNLupin launches Prucalopride tablets in U.S. marketTablets, developed by Takeda Pharmaceuticals U.S.A., Inc. The medication is indicated for the treatment of chronic idiopathic ...
In a shocking revelation that could have grave implications for global cancer care, a recent investigation has uncovered that several chemotherapy drugs manufactured by Indian pharmaceutical companies ...
India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...
Chemotherapy drugs in over 100 countries fail quality tests, putting cancer patients at risk of ineffective treatments.
India's entrepreneurial landscape is undergoing a bold evolution, driven by leaders who are reshaping industries through ...
Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...
HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of ...
China 1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman Sachs
Indian pharmaceutical and biotech sectors have started witnessing tangible benefits from the global shift away from China, as early signs of the China 1 strategy materialising emerge, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results